K080431 is an FDA 510(k) clearance for the RAPIDSENSE DRUGS OF ABUSE PHENCYCLIDINE (PCP) 25 DEVICE WITH MODELS 900-0054. Classified as Enzyme Immunoassay, Phencyclidine (product code LCM).
Submitted by Quantrx Biomedical Corporation (San Diego, US). The FDA issued a Cleared decision on January 8, 2009 after a review of 324 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Toxicology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Toxicology review framework, consistent with the majority of Class II 510(k) submissions.
View all Quantrx Biomedical Corporation devices